Variable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients

Diagnostic Pathology

Volumn 8, Issue 1, 2013, Pages

  Zhang, Guanjun ^a   Qu, Yiping ^a   Dang, Siwen ^a   Yang, Qi ^a   Shi, Bingyin ^a   Hou, Peng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Clinical outcomes; Copy number; Gastric cancer; Mitochondrial DNA (mtDNA); Real time quantitative PCR

Indexed keywords

DNA; MITOCHONDRIAL DNA; TUMOR MARKER;

AGED; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; COPY NUMBER VARIATION; FEMALE; GENETICS; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STOMACH TUMOR;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; DNA COPY NUMBER VARIATIONS; DNA, MITOCHONDRIAL; DNA, NEOPLASM; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84885731393     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-8-173     Document Type: Article

References (39)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. Blakely AM, Miner TJ. Surgical considerations in the treatment of gastric cancer. Gastroenterol Clin North Am 2013, 42:337-357. 10.1016/j.gtc.2013.01.010, 23639644.
3. Tan VP, Wong BC. Gastric cancer chemoprevention: the current evidence. Gastroenterol Clin North Am 2013, 42:299-316. 10.1016/j.gtc.2013.02.001, 23639642.
4. Allgayer H, Heiss MM, Schildberg FW. Prognostic factors in gastric cancer. Br J Surg 1997, 84:1651-1664. 10.1002/bjs.1800841206, 9448610.
5. Sotoudeh K, Hashemi F, Madjd Z, Sadeghipour A, Molanaei S, Kalantary E. The clinicopathologic association of c-MET overexpression in Iranian gastric carcinomas; an immunohistochemical study of tissue microarrays. Diagn Pathol 2012, 7:57. 10.1186/1746-1596-7-57, 3408322, 22640970.
6. Yamaguchi T, Fujimori T, Tomita S, Ichikawa K, Mitomi H, Ohno K, Shida Y, Kato H. Clinical validation of the gastrointestinal NET grading system: Ki67 index criteria of the WHO 2010 classification is appropriate to predict metastasis or recurrence. Diagn Pathol 2013, 8:65. 10.1186/1746-1596-8-65, 3649937, 23607525.
7. Liu X, Xiong H, Li J, He Y, Yuan X. Correlation of hK6 expression with tumor recurrence and prognosis in advanced gastric cancer. Diagn Pathol 2013, 8:62. 10.1186/1746-1596-8-62, 3674969, 23587030.
8. Shan L, Ying J, Lu N. HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population. Diagn Pathol 2013, 8:76. 10.1186/1746-1596-8-76, 3655831, 23656792.
9. Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M, Nakayama H. Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 2005, 8:86-94. 10.1007/s10120-005-0320-0, 15864715.
10. Corso G, Velho S, Paredes J, Pedrazzani C, Martins D, Milanezi F, Pascale V, Vindigni C, Pinheiro H, Leite M, Marrelli D, Sousa S, Carneiro F, Oliveira C, Roviello F, Seruca R. Oncogenic mutations in gastric cancer with microsatellite instability. Eur J Cancer 2011, 47:443-451. 10.1016/j.ejca.2010.09.008, 20937558.
11. Yao D, Shi J, Shi B, Wang N, Liu W, Zhang G, Ji M, Xu L, He N, Hou P. Quantitative assessment of gene methylation and their impact on clinical outcome in gastric cancer. Clin Chim Acta 2012, 413:787-794. 10.1016/j.cca.2012.01.013, 22285775.
12. Qu Y, Dang S, Hou P. Gene methylation in gastric cancer. Clin Chim Acta 2013, 424C:53-65.
13. Shi J, Yao D, Liu W, Wang N, Lv H, Zhang G, Ji M, Xu L, He N, Shi B, Hou P. Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer. BMC Cancer 2012, 12:50. 10.1186/1471-2407-12-50, 3299648, 22292935.
14. Shi J, Yao D, Liu W, Wang N, Lv H, He N, Shi B, Hou P, Ji M. Frequent gene amplification predicts poor prognosis in gastric cancer. Int J Mol Sci 2012, 13:4714-4726. 10.3390/ijms13044714, 3344242, 22606006.
15. Yasui W, Oue N, Kuniyasu H, Ito R, Tahara E, Yokozaki H. Molecular diagnosis of gastric cancer: present and future. Gastric Cancer 2001, 4:113-121. 10.1007/PL00011733, 11760076.
16. Yokozaki H, Yasui W, Tahara E. Genetic and epigenetic changes in stomach cancer. Int Rev Cytol 2001, 204:49-95.
17. Hatefi Y. The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem 1985, 54:1015-1069. 10.1146/annurev.bi.54.070185.005055, 2862839.
18. Wallace DC. Mitochondria and cancer. Nat Rev Cancer 2012, 12:685-698.
19. Shadel GS. Expression and maintenance of mitochondrial DNA: new insights into human disease pathology. Am J Pathol 2008, 172:1445-1456. 10.2353/ajpath.2008.071163, 2408405, 18458094.
20. Chinnery PF, Hudson G. Mitochondrial genetics. Br Med Bull 2013, 106:135-159. 10.1093/bmb/ldt017, 3675899, 23704099.
21. Copeland WC, Wachsman JT, Johnson FM, Penta JS. Mitochondrial DNA alterations in cancer. Cancer Invest 2002, 20:557-569. 10.1081/CNV-120002155, 12094550.
22. Lan Q, Lim U, Liu CS, Weinstein SJ, Chanock S, Bonner MR, Virtamo J, Albanes D, Rothman N. A prospective study of mitochondrial DNA copy number and risk of non-Hodgkin lymphoma. Blood 2008, 112:4247-4249. 10.1182/blood-2008-05-157974, 2582005, 18711000.
23. Hosgood HD, Liu CS, Rothman N, Weinstein SJ, Bonner MR, Shen M, Lim U, Virtamo J, Cheng WL, Albanes D, Lan Q. Mitochondrial DNA copy number and lung cancer risk in a prospective cohort study. Carcinogenesis 2010, 31:847-849. 10.1093/carcin/bgq045, 2864414, 20176654.
24. Lynch SM, Weinstein SJ, Virtamo J, Lan Q, Liu CS, Cheng WL, Rothman N, Albanes D, Stolzenberg-Solomon RZ. Mitochondrial DNA copy number and pancreatic cancer in the alpha-tocopherol beta-arotene cancer prevention study. Cancer Prev Res (Phila) 2011, 4:1912-1919. 10.1158/1940-6207.CAPR-11-0002, 3208722, 21859925.
25. Shen J, Platek M, Mahasneh A, Ambrosone CB, Zhao H. Mitochondrial copy number and risk of breast cancer: a pilot study. Mitochondrion 2010, 10:62-68. 10.1016/j.mito.2009.09.004, 19788937.
26. Qu F, Liu X, Zhou F, Yang H, Bao G, He X, Xing J. Association between mitochondrial DNA content in leukocytes and colorectal cancer risk: a case-control analysis. Cancer 2011, 117:3148-3155. 10.1002/cncr.25906, 21246538.
27. Xing J, Chen M, Wood CG, Lin J, Spitz MR, Ma J, Amos CI, Shields PG, Benowitz NL, Gu J, de Andrade M, Swan GE, Wu X. Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. J Natl Cancer Inst 2008, 100:1104-1112. 10.1093/jnci/djn213, 2720693, 18664653.
28. Wu CW, Yin PH, Hung WY, Li AF, Li SH, Chi CW, Wei YH, Lee HC. Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer. Genes, Chromosomes Cancer 2005, 44:19-28. 10.1002/gcc.20213, 15892105.
29. Lee HC, Yin PH, Lin JC, Wu CC, Chen CY, Wu CW, Chi CW, Tam TN, Wei YH. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci 2005, 1042:109-122. 10.1196/annals.1338.011, 15965052.
30. Liao LM, Baccarelli A, Shu XO, Gao YT, Ji BT, Yang G, Li HL, Hoxha M, Dioni L, Rothman N, Zheng W, Chow WH. Mitochondrial DNA copy number and risk of gastric cancer: a report from the Shanghai Women's Health Study. Cancer Epidemiol Biomarkers Prev 2011, 20:1944-1949. 10.1158/1055-9965.EPI-11-0379, 3169741, 21784958.
31. Hou P, Liu D, Shan Y, Hu S, Studeman K, Condouris S, Wang Y, Trink A, El-Naggar AK, Tallini G, Vasko V, Xing M. Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer. Clin Cancer Res 2007, 13:1161-1170. 10.1158/1078-0432.CCR-06-1125, 17317825.
32. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005, 39:359-407. 10.1146/annurev.genet.39.110304.095751, 2821041, 16285865.
33. Verschoor ML, Ungard R, Harbottle A, Jakupciak JP, Parr RL, Singh G. Mitochondria and cancer: past, present, and future. Biomed Res Int 2013, 2013:612369. 3581248, 23509753.
34. Robin ED, Wong R. Mitochondrial DNA molecules and virtual number of mitochondria per cell in mammalian cells. J Cell Physiol 1988, 136:507-513. 10.1002/jcp.1041360316, 3170646.
35. Clay Montier LL, Deng JJ, Bai Y. Number matters: control of mammalian mitochondrial DNA copy number. J Genet Genomics 2009, 36:125-131. 10.1016/S1673-8527(08)60099-5, 19302968.
36. Burgart LJ, Zheng J, Shu Q, Strickler JG, Shibata D. Somatic mitochondrial mutation in gastric cancer. Am J Pathol 1995, 147:1105-1111. 1871018, 7573355.
37. Tamura G, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Sakata K, Endoh Y, Motoyama T. Mutations in mitochondrial control region DNA in gastric tumours of Japanese patients. Eur J Cancer 1999, 35:316-319. 10.1016/S0959-8049(98)00360-8, 10448277.
38. Lin CS, Chang SC, Wang LS, Chou TY, Hsu WH, Wu YC, Wei YH. The role of mitochondrial DNA alterations in esophageal squamous cell carcinomas. J Thorac Cardiovasc Surg 2010, 139:189-197. 10.1016/j.jtcvs.2009.04.007, 19660406.
39. Lin CS, Lee HT, Lee SY, Shen YA, Wang LS, Chen YJ, Wei YH. High mitochondrial DNA copy number and bioenergetic function are associated with tumor invasion of esophageal squamous cell carcinoma cell lines. Int J Mol Sci 2012, 13:11228-11246. 10.3390/ijms130911228, 3472741, 23109849.